Mycobacterium tuberculosis infects about one-third of the world's population, and causes almost 2 million deaths
annually. In 2007, there were 9.27 million new TB cases. Despite more than 40 years
of anti-TB chemotherapy, tuberculosis remains one of the leading infectious diseases
worldwide. The association with HIV epidemic, the increasing emergence of multi-drug
resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) make TB virtually
untreatable with available drugs [1–3]. From this point, there is evidently an urgent
need to develop new and more effective TB drugs. Natural products, well defined as
providing novel examples of anti-infective drug leads [4], play key roles in the modern
day chemotherapy of tuberculosis. n Mozambique, where has been reported to possess
around 500 plant species using as traditional medicine [5], medicinal plants are an
important part for peoples' basic health care, particularly in rural areas. Due to
limited scientific evidence concerning the uses of these plants, it is crucial to
establish the safety and efficacy for these medicinal plants. This study evaluated
seven plants used in Mozambique traditional medicine to treat tuberculosis and other
respiratory diseases. The antimycobacterial activity for different species of mycobacteria
such as M. smegmatis, M. bovis BCG, M. avium, and M. tuberculosis was assessed using a rapid screening method (Broth Dilution MIC Method). Five crude
extracts of five plants showed promising activity against one or more mycobacterial
species with a MIC ranging from 15µg/mL to 250µg/mL. The data support traditional
uses of these medicinal plants in Mozambique.
Acknowledgements: This study was supported by a fellowship from FCT, Portugal (reference number SFRH/BPD/37179/2007).
References: 1. Corbett E. L. et al. (2003) Arch. Intern. Med. 163:1009–1021.
2. Gomez, J. E. et al. (2004) Tuberculosis (Edinb) 84:29–44.
3. Smith, C. V. et al. (2003)J. Biol. Chem. 278:1735–1743.
4. Newman D.J. et al. (2000) Nat. Prod. Rep. 17:215.
5. Bandeira S. O. et al. Pharm. Biology 2001, 39, 70–73.